These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 20036337)
1. Access to hematopoietic cell transplantation in the United States. Majhail NS; Omondi NA; Denzen E; Murphy EA; Rizzo JD Biol Blood Marrow Transplant; 2010 Aug; 16(8):1070-5. PubMed ID: 20036337 [TBL] [Abstract][Full Text] [Related]
2. Racial disparities in hematopoietic cell transplantation in the United States. Majhail NS; Nayyar S; Santibañez ME; Murphy EA; Denzen EM Bone Marrow Transplant; 2012 Nov; 47(11):1385-90. PubMed ID: 22056642 [TBL] [Abstract][Full Text] [Related]
3. Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics. Hong S; Majhail NS Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):275-280. PubMed ID: 34889386 [TBL] [Abstract][Full Text] [Related]
4. Geographic access to hematopoietic cell transplantation services in the United States. Delamater PL; Uberti JP Bone Marrow Transplant; 2016 Feb; 51(2):241-8. PubMed ID: 26457909 [TBL] [Abstract][Full Text] [Related]
5. Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age. Flannelly C; Tan BE; Tan JL; McHugh CM; Sanapala C; Lagu T; Liesveld JL; Aljitawi O; Becker MW; Mendler JH; Klepin HD; Stock W; Wildes TM; Artz A; Majhail NS; Loh KP Biol Blood Marrow Transplant; 2020 Dec; 26(12):2335-2345. PubMed ID: 32961375 [TBL] [Abstract][Full Text] [Related]
6. Barriers to accessing health care for hematopoietic cell transplantation recipients living in rural areas: perspectives from healthcare providers. Moore HK; Santibañez ME; Denzen EM; Carr DW; Murphy EA Clin J Oncol Nurs; 2013 Aug; 17(4):405-11. PubMed ID: 23899979 [TBL] [Abstract][Full Text] [Related]
7. Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients. Farnia S; Ganetsky A; Silver A; Hwee T; Preussler J; Griffin J; Khera N Biol Blood Marrow Transplant; 2017 Aug; 23(8):1387-1392. PubMed ID: 28412517 [TBL] [Abstract][Full Text] [Related]
8. Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems. Besse KL; Preussler JM; Murphy EA; Denzen EM; Lill MC; Chell JW; Senneka MK; Majhail NS; Williams EP J Oncol Pract; 2015 Mar; 11(2):e120-30. PubMed ID: 25784576 [TBL] [Abstract][Full Text] [Related]
9. Fertility Concerns and Access to Care for Stem Cell Transplantation Candidates with Sickle Cell Disease. Mishkin AD; Mapara MY; Barhaghi M; Reshef R Biol Blood Marrow Transplant; 2020 Aug; 26(8):e192-e197. PubMed ID: 32315707 [TBL] [Abstract][Full Text] [Related]
10. Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings. Dunavin N; Mau LW; Meyer CL; Divine C; Abdallah AO; Leppke S; D'Souza A; Denzen E; Saber W; Burns LJ; Ganguly S Biol Blood Marrow Transplant; 2020 Apr; 26(4):805-813. PubMed ID: 31917269 [TBL] [Abstract][Full Text] [Related]
14. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients. Jabo B; Morgan JW; Martinez ME; Ghamsary M; Wieduwilt MJ PLoS One; 2017; 12(4):e0174760. PubMed ID: 28384176 [TBL] [Abstract][Full Text] [Related]
15. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941 [TBL] [Abstract][Full Text] [Related]
16. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies. Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449 [TBL] [Abstract][Full Text] [Related]
18. Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia. Appelbaum FR Best Pract Res Clin Haematol; 2017 Dec; 30(4):320-326. PubMed ID: 29156203 [TBL] [Abstract][Full Text] [Related]
19. Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers. Preussler JM; Mau LW; Majhail NS; Bevans M; Clancy E; Messner C; Parran L; Pederson KA; Ferguson SS; Walters K; Murphy EA; Denzen EM Support Care Cancer; 2016 Mar; 24(3):1167-74. PubMed ID: 26275767 [TBL] [Abstract][Full Text] [Related]
20. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. Auletta JJ; Sandmaier BM; Jensen E; Majhail NS; Knutson J; Nemecek E; Ajayi-Hackworth F; Davies SM; Transplant Cell Ther; 2022 Dec; 28(12):802-809. PubMed ID: 36184058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]